New Cambridge powerhouse pledges millions to accelerate life science startups – Business Weekly

A new Cambridge powerhouse formed by top life science entrepreneurs and enterprises is launched today that could see up to £12.5 million pumped into scaling the UK clusters most promising bio startups in the next five years. Start Codon pledges to propel 50 startups to the brink of crucial Series A rounds. 

It will invest up to £250k into each of 50 startups in the initial five-year window – and it will incubate these rising stars in office and lab space at the Milner Therapeutics Institute; experienced mentors will be deployed to maximise opportunities.

Long on ideas but short on experience? Start Codon has some cash and a place for you in the Golden Triangle

Start Codons vision is to provide a much-needed world-class life science accelerator that offers significant funding and support to rapidly translate the most disruptive and innovative research into successful start-up companies.

Record-breaking sums of venture bets on UK healthcare may have ushered in a spring for more mature companies, but it has also raised the bar on smaller shops just getting started, sometimes starving promising ideas of the necessary capital to move forward.

Founding investors include Cambridge Innovation Capital, Babraham Research Campus through Babraham Bioscience Technologies, Genentech, a member of the Roche Group, Dr Jonathan Milner and Dr Ian Tomlinson. The venture is now accepting applications. Early stage start-up companies in the life sciences and healthcare space are invited to apply via startcodon.co .

Thats according to the founders of Start Codon, a startup accelerator launching at the heart of the Cambridge Cluster to invest on behalf of Cambridge Innovation Capital, Babraham Research Campus and Roches Genentech.

Start Codons executive team will be led by Dr Jason Mellad, previously CEO of Cambridge Epigenetix, which he transformed into a liquid biopsy diagnostic development firm via obtaining broad and exclusive patent rights to the use of epigenetic biomarker 5hmC in cancer diagnostics and leading a successful Series C fundraise of c.$30m. 

Mellad brings over a decade of experience in product development and commercialisation, building and managing cross-disciplinary teams, intellectual property protection and exploitation, and closing deals with strategic biotech and pharma partners. 

Dr Ian Tomlinson has been appointed chairman. He is also chair of Apollo Therapeutics and the Stevenage Bioscience Catalyst and has over 25 years of experience in the life sciences sector from academic research to biotech startup to big pharma. 

He founded Domantis Limited with Sir Gregory Winter, which was acquired by GSK in 2006 for $454 million. He then served as senior VP, head of Worldwide Business Development and head of Biopharm R & D at GSK. 

Dr Mellad and Dr Tomlinson will be joined by Michael Anstey of Cambridge Innovation Capital, Jo Parfrey and Jonathan Milner as directors. Dr Mellad said: Our ambition is to provide life science and healthcare companies with a unique combination of funding, facilities, mentoring and support to fast track their development and success. 

We are selecting the most exciting pre-Series A companies from around the world, and bringing them to Cambridge, helping to solidify the regions position as a leading global cluster.

Dr Michael Anstey, investment director at Cambridge Innovation Capital, added: Cambridge is the best place in Europe to build a life science business. 

Start Codon will bring together all the key elements here, to enable emerging companies to rapidly embark on their growth journey. We are proud to have been part of the Start Codon initiative from inception and we are excited to support the world class businesses that will emerge from its programme in the future. 

The Cambridge ecosystem has already created over a dozen billion-pound businesses and we see Start Codon as an important facilitator in creating more such successes.

Jonathan Milner believes this is the dawn of a new golden era for Cambridge life science innovators. He said: Start Codons innovative supercharged model will establish nurture and spin out the next generation of world-class healthcare companies that will positively impact all our lives.

I am super thrilled to be working with such an esteemed and experienced set of stakeholders to guarantee the success of Start Codon. We look forward to enabling the next generation of Cambridge healthcare unicorns.

CAMBRIDGE, England–(BUSINESS WIRE)–Start Codon, a new strategic initiative aimed at driving the translation of world-class research into commercially successful companies, has been founded and launched with funding from keystone investors including Cambridge Innovation Capital, Babraham Bioscience Technologies, Genentech, a member of the Roche Group, Dr Jonathan Milner and Dr Ian Tomlinson.

Start Codon will identify and recruit high potential life science and healthcare companies from across the UK and beyond, provide seed-funding, and leverage the world-class resources of the Cambridge Cluster to reduce risk and prepare them for a successful Series A fundraise. The accelerator will be the first within the Cambridge Cluster to provide life science start-ups with significant investment (up to £250K), a full-time dedicated team of experienced and active mentors, and office and lab space (located at the Milner Therapeutics Institute). Start Codon now plans to invest in and support up to 50 start-up companies over the next 5 years.

Start Codons executive team will be led by Dr Jason Mellad, previously CEO of Cambridge Epigenetix, which he transformed into a liquid biopsy diagnostic development firm via obtaining broad and exclusive patent rights to the use of epigenetic biomarker 5hmC in cancer diagnostics and leading a successful Series C fundraise of c.$30m. Jason brings over a decade of experience in product development and commercialisation, building and managing cross-disciplinary teams, intellectual property protection and exploitation, and closing deals with strategic biotech and pharma partners.

Dr Ian Tomlinson has been appointed Chairman of the Start Codon Board. Dr Tomlinson is also Chairman of Apollo Therapeutics and the Stevenage Bioscience Catalyst. He has over 25 years of experience in the life sciences sector from academic research to biotech start-up to big pharma. He founded Domantis Limited with Sir Gregory Winter, which was acquired by GSK in 2006 for $454 million. He then served as Senior VP, Head of Worldwide Business Development and Head of Biopharm R&D at GSK. Dr Mellad and Dr Tomlinson will be joined by Michael Anstey of Cambridge Innovation Capital, Jo Parfrey and Jonathan Milner as Directors of Start Codon.

Dr Jason Mellad, CEO Start Codon, said: Our ambition is to provide life science and healthcare companies with a unique combination of funding, facilities, mentoring and support to fast track their development and success. We are selecting the most exciting pre-Series A companies from around the world, and bringing them to Cambridge, helping to solidify the regions position as a leading global cluster.

Dr James Sabry, M.D., Ph.D., global head of Pharma Partnering, Roche, said: Were very pleased to support Start Codon in harnessing the best research from the region and fostering healthcare innovation at its earliest stages. We believe some of the most cutting-edge science in the world is happening in Cambridge, and this investment builds on our commitment to driving scientific advances within the UK and globally.

Dr Michael Anstey, Ph.D., Investment Director at Cambridge Innovation Capital, added: Cambridge is the best place in Europe to build a life science business. Start Codon will bring together all the key elements here, to enable emerging companies to rapidly embark on their growth journey. We are proud to have been part of the Start Codon initiative from inception and we are excited to support the world class businesses that will emerge from its programme in the future. The Cambridge ecosystem has already created over a dozen billion-pound businesses and we see Start Codon as an important facilitator in creating more such successes.

Dr Jonathan Milner, Ph.D., Co-founder and Deputy Chairman of Abcam plc, commented: In this golden age of biology, Cambridge stands out as the worlds centre for healthcare innovation and translation. Start Codons innovative supercharged model will establish nurture and spin out the next generation of world class healthcare companies that will positively impact all our lives. I am super thrilled to be working with such an esteemed and experienced set of stakeholders to guarantee the success of Start Codon. We look forward to enabling the next generation of Cambridge healthcare unicorns.

Jo Parfrey, a Non-Executive Director at Babraham Bioscience Technologies Ltd who will represent the company on the Start Codon Board, commented: We are delighted to be involved in the Start Codon initiative as it looks to identify, support and develop future scale-up life-sciences companies. Our aim as a Campus is to not only positively impact the local Cambridge cluster, but also bio-science across the UK. As an ideal location to accommodate these ventures as they mature through the Start Codon journey, we hope to play a significant part in facilitating the next generation of innovative and entrepreneurial companies. We see the Start Codon initiative as complementary to our ongoing [email protected] programme and are looking forward to working together to ensure these young ventures have access to the facilities and opportunities which will help them to develop successfully.

The first cohort of 5 companies is now being recruited. Start Codon is looking for companies with disruptive innovations that will revolutionise modern healthcare and platform technologies underpinned by strong intellectual property, with a particular emphasis on novel therapeutics, diagnostics, medtech and digital health.

More news:

Cambridge research into driverless cars finds improved traffic flow – BBC News
Cambridge research into driverless cars finds improved traffic flow – BBC News
Driverless cars: Cambridge University model cars talk to avoid jams – BBC News
Driverless cars: Cambridge University model cars talk to avoid jams – BBC News
Prince George, Princess Charlotte, Prince Louis, Kate Middleton, & Prince William Play In Chelsea Flower Garden – HarpersBAZAAR.com
Prince George, Princess Charlotte, Prince Louis, Kate Middleton, & Prince William Play In Chelsea Flower Garden – HarpersBAZAAR.com
George gives Duchess of Cambridge 20 out of 10 for her Chelsea garden – Telegraph.co.uk
George gives Duchess of Cambridge 20 out of 10 for her Chelsea garden – Telegraph.co.uk
The Queen and Cambridge children visit Kates 20 out of 10 Chelsea Flower Show garden ahead of its opening – ITV News
The Queen and Cambridge children visit Kates 20 out of 10 Chelsea Flower Show garden ahead of its opening – ITV News
The Queen and Cambridge children visit Kates Chelsea Flower Show garden ahead of its opening – ITV News
The Queen and Cambridge children visit Kates Chelsea Flower Show garden ahead of its opening – ITV News
Duchess of Cambridge urges children to sit and feel real nature in Instagram age – Telegraph.co.uk
Duchess of Cambridge urges children to sit and feel real nature in Instagram age – Telegraph.co.uk
Cambridge children visit mum Kates Chelsea Flower Show ahead of its opening – ITV News
Cambridge children visit mum Kates Chelsea Flower Show ahead of its opening – ITV News
Duchess of Cambridge posts sneak peek of Chelsea show garden – BBC News
Duchess of Cambridge posts sneak peek of Chelsea show garden – BBC News
Duchess of Cambridge posts sneak peak of Chelsea show garden – BBC News
Duchess of Cambridge posts sneak peak of Chelsea show garden – BBC News
Duchess of Cambridge to unveil Chelsea Flower Show garden inspired by Norfolk estate – Eastern Daily Press
Duchess of Cambridge to unveil Chelsea Flower Show garden inspired by Norfolk estate – Eastern Daily Press
Duchess of Cambridge to unveil Chelsea Flower Show garden | Latest Norfolk and Suffolk News – Eastern Daily Press
Duchess of Cambridge to unveil Chelsea Flower Show garden | Latest Norfolk and Suffolk News – Eastern Daily Press